PagnatoKarp Partners’s Eli Lilly LLY Stock Holding History

PagnatoKarp Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,913	Closed	-$1.38M	–	82
2020 Q1	$1.38M	Hold	9,913	–	–	0.34%	47
2019 Q4	$1.3M	Sell	9,913 -37	-0.4%	-$4.29K	0.23%	53
2019 Q3	$1.11M	Sell	9,950 -111	-1%	-$12.4K	0.22%	60
2019 Q2	$1.11M	Buy	10,061 +208	+2%	+$24.5K	0.24%	55
2019 Q1	$1.28M	Sell	9,853 -25	-0.3%	-$3.04K	0.29%	50
2018 Q4	$1.14M	Buy	9,878 +22	+0.2%	+$2.46K	0.24%	52
2018 Q3	$1.06M	Hold	9,856	–	–	0.31%	48
2018 Q2	$841K	Buy	9,856 +1,704	+21%	+$140K	0.27%	54
2018 Q1	$631K	Sell	8,152 -1,658	-17%	-$133K	0.27%	65
2017 Q4	$829K	Sell	9,810 -42	-0.4%	-$3.57K	0.24%	60
2017 Q3	$843K	Buy	9,852 +56	+0.6%	+$4.59K	0.21%	59
2017 Q2	$806K	Buy	9,796 +3	+0%	+$245	0.24%	58
2017 Q1	$824K	Sell	9,793 -108	-1%	-$8.65K	0.24%	53
2016 Q4	$729K	Buy	+9,901	New	+$737K	0.22%	59

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PagnatoKarp Partners's LLY Position: Q2 2020 in Review

PagnatoKarp Partners sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 9,913 shares — an estimated $1.38M sold.

PagnatoKarp Partners first reported a position in LLY in Q4 2016 and held it in 14 quarters. The position peaked at $1.38M in Q1 2020. 1,765 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

PagnatoKarp Partners reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
PagnatoKarp Partners sold 9,913 Eli Lilly shares in Q2 2020, an estimated $1.38M.
PagnatoKarp Partners first reported a position in Eli Lilly in Q4 2016 and held it in 14 quarters.
PagnatoKarp Partners's Eli Lilly position peaked at $1.38M in Q1 2020.
1,765 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on PagnatoKarp Partners's 13F filing for Q2 2020.